Literature DB >> 1422283

Autocrine growth factors and leukaemic haemopoiesis.

N H Russell1.   

Abstract

Studies on the structure of haemopoiesis in acute myeloblastic leukaemia (AML) has shown the presence of a small population of malignant cells with extensive proliferative and self-renewal properties which are features of stem cells. The requirements of these cells for proliferation have been studied both in clonogenic assays in semi-solid media and in liquid suspension culture. These have demonstrated that AML clonogenic cells from the majority of patients, can be stimulated to proliferate by colony-stimulating factors (GM-CSF, G-CSF and IL-3) as well as other cytokines including interleukin-1 and interleukin-6, all of which are known to stimulate normal haemopoietic progenitors. Unlike normal haemopoietic cells, leukaemic blasts from many patients with AML express transcripts for haemopoietic growth factors including GM-CSF, G-CSF and IL-1 but not IL-3, and secrete growth factor protein. When leukaemic cells are cultured at sufficiently high density to permit cell-cell interactions, autonomous growth of clonogenic cells can be seen. Autonomous growth is related to the autocrine secretion of haemopoietic growth factors including GM-CSF, G-CSF and IL-6. The degree of autonomous colony growth is variable but approximately 70% of AML samples exhibit either partial or totally autonomous growth; the remaining cells being absolutely dependent on exogenous CSF or fail to grow in the culture systems employed. Similar patterns of growth have been found in murine haemopoietic cells lines which have been transformed as the result of the retroviral insertion of genes for GM-CSF or IL-3.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1422283     DOI: 10.1016/0268-960x(92)90026-m

Source DB:  PubMed          Journal:  Blood Rev        ISSN: 0268-960X            Impact factor:   8.250


  11 in total

Review 1.  Haemopoietic growth factors.

Authors:  N J Ketley; A C Newland
Journal:  Postgrad Med J       Date:  1997-04       Impact factor: 2.401

2.  Recurrent expression signatures of cytokines and chemokines are present and are independently prognostic in acute myelogenous leukemia and myelodysplasia.

Authors:  Steven M Kornblau; David McCue; Neera Singh; Wenjing Chen; Zeev Estrov; Kevin R Coombes
Journal:  Blood       Date:  2010-08-02       Impact factor: 22.113

3.  Deoxyribonucleic acid triplex formation inhibits granulocyte macrophage colony-stimulating factor gene expression and suppresses growth in juvenile myelomonocytic leukemic cells.

Authors:  M Kochetkova; P O Iversen; A F Lopez; M F Shannon
Journal:  J Clin Invest       Date:  1997-06-15       Impact factor: 14.808

4.  Interleukin-8 blockade prevents activated endothelial cell mediated proliferation and chemoresistance of acute myeloid leukemia.

Authors:  Vindhya Vijay; Regan Miller; Gau Shoua Vue; Mida Bahareh Pezeshkian; Michael Maywood; Allison M Ast; Leylah M Drusbosky; Yuri Pompeu; Alan D Salgado; Samuel D Lipten; Timothy Geddes; Ann Marie Blenc; Yubin Ge; David A Ostrov; Christopher R Cogle; Gerard J Madlambayan
Journal:  Leuk Res       Date:  2019-07-03       Impact factor: 3.156

5.  High expression of suppressor of cytokine signaling-2 predicts poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology Group.

Authors:  George S Laszlo; Rhonda E Ries; Chelsea J Gudgeon; Kimberly H Harrington; Todd A Alonzo; Robert B Gerbing; Susana C Raimondi; Betsy A Hirsch; Alan S Gamis; Soheil Meshinchi; Roland B Walter
Journal:  Leuk Lymphoma       Date:  2014-03-24

6.  Specific human granulocyte-macrophage colony-stimulating factor antagonists.

Authors:  T R Hercus; C J Bagley; B Cambareri; M Dottore; J M Woodcock; M A Vadas; M F Shannon; A F Lopez
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-21       Impact factor: 11.205

7.  The inducible tissue-specific expression of the human IL-3/GM-CSF locus is controlled by a complex array of developmentally regulated enhancers.

Authors:  Euan W Baxter; Fabio Mirabella; Sarion R Bowers; Sally R James; Aude-Marine Bonavita; Elisabeth Bertrand; Ruslan Strogantsev; Abbas Hawwari; Andrew G Bert; Andrea Gonzalez de Arce; Adam G West; Constanze Bonifer; Peter N Cockerill
Journal:  J Immunol       Date:  2012-09-28       Impact factor: 5.422

Review 8.  The possible diagnostic and prognostic use of systemic chemokine profiles in clinical medicine—the experience in acute myeloid leukemia from disease development and diagnosis via conventional chemotherapy to allogeneic stem cell transplantation.

Authors:  Håkon Reikvam; Hanne Fredly; Astrid Olsnes Kittang; Oystein Bruserud
Journal:  Toxins (Basel)       Date:  2013-02-18       Impact factor: 4.546

Review 9.  G-CSF/GM-CSF-induced hematopoietic dysregulation in the progression of solid tumors.

Authors:  Kai He; Xi Liu; Robert D Hoffman; Rong-Zhen Shi; Gui-Yuan Lv; Jian-Li Gao
Journal:  FEBS Open Bio       Date:  2022-06-09       Impact factor: 2.792

10.  Wild-type p53 is required for apoptosis induced by growth factor deprivation in factor-dependent leukaemic cells.

Authors:  Y M Zhu; D A Bradbury; N H Russell
Journal:  Br J Cancer       Date:  1994-03       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.